Skip to main content
SpringerLink
Log in

Other Rare Extranodal Lymphomas

  • Chapter
  • First Online:
PET/CT in Lymphomas

  • 1072 Accesses

Abstract

Primary bone lymphoma (PBL) is a rare disease exclusively involving the skeleton, accounting for <5 % of extra-nodal lymphomas and 1–2 % of all lymphomas in adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fletcher CDM (2006) The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48:3–12

    Article  CAS  PubMed  Google Scholar 

  2. Messina C, Ferreri AJ, Govi S et al (2014) Clinical features, management and prognosis of multifocal primary bone lymphoma:a retrospective study of the international Extranodal Lymphoma Study Group (the IELSG 14 study). Br J Haematol 164(6):834–840

    Article  PubMed  Google Scholar 

  3. Heyning FH, Hogendoorn PCW, Kramer MHH et al (1999) Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 13:2094–2098

    Article  CAS  PubMed  Google Scholar 

  4. Mikhaeell NG (2012) Primary bone lymphoma, overview. Clin Oncol 24:366e–370e

    Article  Google Scholar 

  5. Wu H, Zhang L, Shao H et al (2014) Prognostic significance of soft tissue extension, International Prognostic Index, and multifocality in primary bone lymphoma: a single institutional experience. Br J Haematol 166:60–68

    Article  PubMed  Google Scholar 

  6. Messina C, Christie D, Zucca E et al (2015) Primary and secondary bone lymphomas. Tumor review. Cancer Treat Rev 41:235–246

    Article  PubMed  Google Scholar 

  7. Ramadan KM, Shenkier T, Sehn LH et al (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 18(1):129–135

    Article  CAS  PubMed  Google Scholar 

  8. Paes FM, Kalkanis DG, Sideras PA et al (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. RSNA Radiographics 30:269–291

    Article  Google Scholar 

  9. Das J, Ray S, Sen S et al (2014) Extranodal involvement in lymphoma-a pictorial essay and retrospective analysis of 281 PET/CT studies. Asia Oceania J Nucl Med Biol 2(1):42–56

    Google Scholar 

  10. Moog F, Kotzerke JK, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413

    CAS  PubMed  Google Scholar 

  11. Ilica AT, Kocacelebi K, Savas R (2011) Imaging of extranodal lymphoma with PET/CT. Clin Nucl Med 36:e127–e138

    Article  PubMed  Google Scholar 

  12. Guermazi A, Brice P, de Kerviler EE et al (2001) Extra-nodal Hodgkin disease: spectrum of disease. Radiographics 21:161–179

    Article  CAS  PubMed  Google Scholar 

  13. Chua SC, Rozalli FI, O’Connor S (2009) Imaging features of primary extranodal lymphomas. Clin Radiol 64:574–588

    Article  CAS  PubMed  Google Scholar 

  14. Pellegrini C, Gandolfi L, Quirini F et al (2011) Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients. Clin Lymphoma Myeloma Leuk 11:321–325

    Article  CAS  PubMed  Google Scholar 

  15. Guirguis HR, Cheung MC, Mahrous M et al (2012) Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single center experience and review of the literature. Br J Haematol 159:39–49

    Article  CAS  PubMed  Google Scholar 

  16. Fletcher CD, Bridge JA, Hogendoorn PC et al (2013) WHO classification of tumors of soft tissue and bone. World Health Organization, IARC, Lyon

    Google Scholar 

  17. Mengiardi B, Honegger H, Hodler J et al (2005) Primary lymphoma of bone: MRI and CT characteristics during and after successful treatment. AJR Am J Roentgenol 184(1):185–192

    Article  PubMed  Google Scholar 

  18. Mohamed M, Brain T, Sharma S (2013) Multifocal primary bone lymphoma: durable complete remission after R-CHOP chemotherapy. BMJ Case Rep. doi:10.1136/bcr-2013-009809

    Google Scholar 

  19. Ma J, Wang Y, Zhao H et al (2014) Clinical characteristics of 26 patients with primary extranodal Hodgkin lymphoma. Int J Clin Exp Pathol 7(8):5045–5050

    PubMed  PubMed Central  Google Scholar 

  20. Iyengar P, Mazloom A, Shihadeh F et al (2010) Hodgkin lymphoma involving extranodal and nodal head and neck sites characteristics and outcomes. Cancer 116(16):3825–3829

    Article  PubMed  Google Scholar 

  21. Gota VS, Gujral S, Nair R et al (2009) Positron emission tomography/computerized tomography evaluation of primary Hodgkins disease of liver. Ind J Cancer 46(3):237–239

    Article  CAS  Google Scholar 

  22. Chim CS, Choy C, Ooi CG et al (2000) Hodgkin’s disease with primary manifestation in the liver. Leuk Lymphoma 37:629–632

    Article  CAS  PubMed  Google Scholar 

  23. Saboo SS, Krajewski KM, O’Regan KN et al (2012) Spleen in haematological malignancies: spectrum of imaging findings. Br J Radiol 85(1009):81–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Karlo CA, Stoolzmann P, Do RK et al (2013) Computed tomography of the spleen: how to interpret the hypodense lesion. Insights Imaging 4:65–76

    Article  PubMed  PubMed Central  Google Scholar 

  25. Daskalogiannaki M, Prassopoulos P, Katrinakis G et al (2001) Splenic involvement in lymphomas: evaluation on serial CT examinations. Acta Radiol 42:326–332

    CAS  PubMed  Google Scholar 

  26. Rini JN, Leonidas JC, Tomas MB et al (2003) 18 F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 44:1072–1074

    PubMed  Google Scholar 

  27. Gallamini A, Borra A (2014) Role of PET in lymphoma. Curr Treat Options Oncol 15:248–261

    Article  PubMed  Google Scholar 

  28. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 20:3050–3067

    Google Scholar 

  29. de Jong PA, van Ufford HM, Baarslag HJ et al (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. Am J Roentgenol 192:745–753

    Article  Google Scholar 

  30. Juweid ME (2011) FDG-PET/CT in lymphoma. Positron emission tomography. Methods Mol Biol 727:1–19

    Article  PubMed  Google Scholar 

  31. Kostakoglu L, Agress H, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315–340

    Article  PubMed  Google Scholar 

  32. Purohit BS, Ailianou A, Dulguerov N et al (2014) FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging 5:585–602

    Article  PubMed  PubMed Central  Google Scholar 

  33. Weiler-Sagie M, Bushelev O, Epelbaum R et al (2010) (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51(1):25–30

    Article  PubMed  Google Scholar 

  34. Kappelman MD, Farkas DK, Long MD et al (2014) Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow up. Clin Gastroenterol Hepatol 12(2):265–273

    Article  PubMed  PubMed Central  Google Scholar 

  35. Sacks EL, Donaldson SS, Gordon J et al (1978) Epithelioid granulomas associated with Hodgkin’s disease: clinical correlations with 55 previously un-treated patients. Cancer 41:562–567

    Article  CAS  PubMed  Google Scholar 

  36. Paydas S, Yavuz S, Disel U et al (2002) Granulomatous reaction after chemotherapy for Hodgkin’s disease. Leuk Res 26:967–970

    Article  CAS  PubMed  Google Scholar 

  37. Coyne JD (2006) Crohn’s disease with inflammatory splenic granuloma. J Clin Pathol 59(8):889

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Barrington SF, Mikhaeel NG, Kostekoglou L et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32:3048–3058

    Article  PubMed  Google Scholar 

  39. Follows GA, Ardeshna KM, Barrington SF et al (2014) Guidelines for the first line management of classical Hodgkin lymphoma. British Committee for Standards in Haematology. Br J Haematol 166(1):34–49. doi: 10.1111/bjh.12878. Epub 2014 Apr 9.

    Google Scholar 

  40. Connors JM (2011) Hodgkin’s lymphoma-the great teacher. N Engl J Med 365(3):264–265

    Article  CAS  PubMed  Google Scholar 

  41. Magagnoli M, Marzo K, Balzarotti M et al (2011) Dimension of residual CT scan mass in Hodgkin’s Lymphoma (HL) is a negative prognostic factor in patients with PET negative after chemo+/−radiotherapy. Blood 118:93

    Article  Google Scholar 

  42. Munker R, Glass J, Griffen LK et al (2004) Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin’s disease. Ann Oncol 15:1699–1704

    Article  CAS  PubMed  Google Scholar 

  43. Ryu JS, Um JW, Min BW (2010) Inflammatory pseudotumour of the spleen: the findings on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). ANZ J Surg 80(9):650–652

    Article  PubMed  Google Scholar 

  44. Adams H, Keijsers RG, Korenromp IH, Grutters JC (2014) FDG PET for gauging of sarcoid disease activity. Semin Respir Crit Care Med 35(3):352–361

    Article  PubMed  Google Scholar 

  45. Balink H, Bennink RJ, Veeger NJ et al (2014) Diagnostic utility of (18) F-FDG PET/CT in inflammation of unknown origin. Clin Nucl Med 39(5):419–425

    Article  PubMed  Google Scholar 

  46. Stathis A, Younes A (2015) The new therapeutical scenario of Hodgkin lymphoma. Ann Oncol 26(10):2026–2033. doi:10.1093/annonc/mdv256

    Article  CAS  PubMed  Google Scholar 

  47. Kuruvilla J, Keating A, Crump M (2011) How I treat relapsed and refractory Hodgkin lymphoma. Blood 117(16):4208–4217

    Article  CAS  PubMed  Google Scholar 

  48. Moskowitz CH, Matasar MJ, Zelenetz AD et al (2012) Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood 119(7):1665–1670

    Google Scholar 

  49. Chan CC, Rubenstein JL, Coupland SE et al (2011) Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium. Oncologist 16:1589–1599

    Article  PubMed  PubMed Central  Google Scholar 

  50. Hwang CS, Yeh S, Bergstrom CS (2014) Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how? Int Ophthalmol Clin 54(2):155–171

    Article  PubMed  PubMed Central  Google Scholar 

  51. Levasseur SD, Wittenberg LA, White VA (2013) Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol 131:50–55

    Article  PubMed  Google Scholar 

  52. Saggo MS, Mehta H, Swampillai AJ et al (2014) Primary intraocular lymphoma. Surv Ophthalmol 59(5):503–516

    Article  Google Scholar 

  53. Davis JL (2013) Intraocular lymphoma: a clinical perspective. Eye (Lond) 27:153–162

    Article  CAS  Google Scholar 

  54. Ferreri AJM (2014) Risk of CNS dissemination in extranodal lymphomas. Lancet Oncol 15:159–169

    Article  Google Scholar 

  55. Mulay K, Narula R, Santosh HG (2015) Primary vitreoretinal lymphoma. Indian J Ophthalmol 63(3):180–186

    Article  PubMed  PubMed Central  Google Scholar 

  56. Martelli M, Ceriani L, Zucca E (2014) [18F]fluorodeoxyglucose positron emission tomograph predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. J Clin Oncol 32:1769–1775

    Article  PubMed  Google Scholar 

  57. Kawai N, Miyake K, Yamamoto Y (2013) 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma. Biomed Res Int. doi:10.1155/2013/247152, Epub 2013 Jun 17. Review

    PubMed  PubMed Central  Google Scholar 

  58. Kawai N, Okubo S, Miyake K et al (2010) Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Ann Nucl Med 24:335–343

    Article  PubMed  Google Scholar 

  59. Yamaguchi S, Hirata K, Kobayashi H (2014) The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma. Ann Nucl Med 28:603–609

    Article  CAS  PubMed  Google Scholar 

  60. Karantanis D, O’Neill BP, Subramaniam RM et al (2007) Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Clin Nucl Med 32:271–274

    Article  PubMed  Google Scholar 

  61. Maza S, Buchert R, Brenner W et al (2013) Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphomas. Radiol Oncol 47:103–110

    Article  PubMed  PubMed Central  Google Scholar 

  62. Grimm SA, Pulido JS, Jahnke K et al (2007) Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol 18:1851–1855

    Article  CAS  PubMed  Google Scholar 

  63. Hashida N, Ohguro N, Nishida K (2012) Efficacy and complications of Intravitreal Rituximab Injection for treating Primary Vitreoretinal Lymphoma. Trans Vis Sci Technol 1:1

    Article  Google Scholar 

  64. Chan CC, Sen HN (2013) Current concepts in diagnosing and managing primary vitroretinal (intraocular) lymphoma. Discov Med 15(81):93–100

    PubMed  PubMed Central  Google Scholar 

  65. Riemens A, Bromberg J, Touitou V (2015) Treatment strategies in primary vitreoretinal lymphoma a 17-Center European Collaborative Study. JAMA Ophthalmol 133(2):191–197

    Article  PubMed  Google Scholar 

  66. Rodriguez EF, Sepah YJ, Jang HS et al (2014) Cytologic features in vitreous preparations of patients with suspicion of intraocular lymphoma. Diagn Cytopathol 42(1):37–44

    Article  PubMed  PubMed Central  Google Scholar 

  67. Matsuo T, Ishimura K, Ichigawa T et al (2009) Positron emission tomography/computed tomography after immunohistochemical and clonal diagnosis of intraocular lymphoma with vitrectomy cell blocks. J Clin Exp Hematopathol 49:77–87

    Article  Google Scholar 

  68. Zanni M, Moulin-Romsee G, Servois V et al (2012) Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience. Hematology 17:768

    Article  Google Scholar 

  69. Larkin KL, Saboo US, Comer GM et al (2014) Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol 98:99–103

    Article  PubMed  Google Scholar 

  70. Hanson JA, Alexandru D, Bota DA (2013) The evaluation and treatment of primary intraocular lymphoma. J Cancer Ther Res 2:15

    Article  Google Scholar 

  71. Hoang-Xuan K, Bessell E, Bromberg J, et al, for the European Association for Neuro-Oncology Task Force on Primary CNS Lymphoma (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 16:e322–e333

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank to Dr Alexandros Charonis, ophthalmologist, Athens Vision Center Eye Institute, Athens Greece, and Dr Nicol Panou, ophthalmologist, Agii Anargiri General Cancer Hospital, Kifissia Athens, Greece, for the ophthalmologic history.

  The author C.S. would like to express her gratitude to the staff of the Stanford Hospital Health Library Palo Alto CA, for their kindness and encouragement as well as their support in the search of the literature.

Author information

Authors and Affiliations

  1. Haematologist, Department of Haematology, Agioi Anargiroi General & Oncological Hospital, N. Kifissia, Raidestou 2, Athens, 16122, Greece

    Catherine G. Stefanoudaki-Sofianatou MD, PhD

  2. Nuclear Medicine Department, Evangelismos Hospital, G.N.A. “ANNUNCIATION”, Ypsilantou 45-47, Athens, 10676, Greece

    Chariklia D. Giannopoulou

  3. Ultrasound, Curator Department of PET/CT, D.TH.K.A. “HEALTH”, Kifissias Av. & Q. Cross 4, Maroussi, 15123, Greece

    Dimitrios T. Kechagias

Authors
  1. Catherine G. Stefanoudaki-Sofianatou MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chariklia D. Giannopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dimitrios T. Kechagias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine G. Stefanoudaki-Sofianatou MD, PhD .

Editor information

Editors and Affiliations

  1. Hygeia and Mitera Hospital, Athens, Greece

    John A. Andreou

  2. Hygeia Hospital, Medical Oncology Department, Athens, Greece

    Paris A. Kosmidis

  3. National & Kapodistrian University, Radiology (emeritus), Athens, Greece

    Athanasios D. Gouliamos

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Stefanoudaki-Sofianatou, C.G., Giannopoulou, C.D., Kechagias, D.T. (2016). Other Rare Extranodal Lymphomas. In: Andreou, J., Kosmidis, P., Gouliamos, A. (eds) PET/CT in Lymphomas. Springer, Cham. https://doi.org/10.1007/978-3-319-27380-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27380-8_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27378-5

  • Online ISBN: 978-3-319-27380-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation